Biological treatment options for severe asthma in Poland

• Egile Nagusiak: Maciej Superson (Egilea), Klaudia Wilk-Trytko (Egilea), Katarzyna Szmyt (Egilea), Sylwia Samojedny (Egilea), Katarzyna Szymańska (Egilea), Kamil Walczak (Egilea), Julia Krasnoborska (Egilea), Julia Zarębska (Egilea)
• Formatua: Liburua
• Argitaratua: Kazimierz Wielki University, 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Intruduction and purpose: Patients with severe asthma account for approximately 3% to 10% of all asthma patients. They have higher hospital utilization rates and treatment costs than patients with non-severe asthma. Previously, treatment options for these patients were limited due to unacceptable si...